What does Brexit mean for life science in Wales?
What will happen next is a burning question for our community and at the very least planning ahead is going to be difficult in the face of the very unpredictable consequences of the referendum vote. A lot will depend on whether access to the single market is retained, but for now it is business as usual and although we are faced with a complex situation and uncertain future there are also potential opportunities with the changes and challenges.
MediWales is running a dedicated seminar event to discuss, inform and debate the potential impact of Brexit for our members. We will bring together expert presentations and discussions on regulation, funding, finance, procurement, legal and recruitment to give insight, support and guidance in challenging times.
Ian Jones, Senior Research Officer for Public Policy Institute for Wales will introduce the event with their research on what Brexit will mean for Wales.
Welcome from Swansea University
Introduction from MediWales
Public Policy Institute for Wales – Ian Jones – What will Brexit mean for Wales?
Overview of Brexit – How did we get here?
- Geldards – Owen Evans and Hayley Lewis
Brexit: The Mechanics, Public Procurement and Implications for Contracts
- Capital Law – Richard Thomas
Brexit – What changes to expect
- Abel & Imray – Simon Haslam
- Wynne-Jones – Elliott Davies
A Company Perspective
- Elite – Shaun McBride
Impact on the Medical Device Directive
- SMTL – Pete Phillips
Brexit, Medical Device standards and Regulation
Potential Financial and Investment Implications
- Grant Thornton – Lee Waterson
- Centurion VAT Specialists – Liz Maher
- Lloyds Bank – Nicholas Stork
The market view on where FX rates may go and strategies businesses can implement to manage these risks
Panel Discussion Q&A
This event is free for members to attend and £125 + VAT for non-members.